3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
20
Head & Neck
2
Gastrointestinal
2
Other neoplasm
1
Gynecologic
1
Breast
1
Conditions
Ovarian Neoplasms
11
Carcinoma, Ovarian Epithelial
11
Uterine Cervical Neoplasms
6
Fallopian Tube Neoplasms
6
Breast Neoplasms
5
Endometrial Neoplasms
3
Uterine Cervical Dysplasia
2
Testicular Neoplasms
2
Sarcoma
2
Salivary Gland Neoplasms
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Liver Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Wilms Tumor
1
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Rhabdoid Tumor
1
Recurrence
1
Prostatic Neoplasms
1
Interventions
pembrolizumab
19
Paclitaxel
10
Carboplatin
10
Magnetic Resonance Spectroscopy
9
Docetaxel
9
Cyclophosphamide
9
Specimen Handling
8
Cisplatin
8
Gemcitabine
7
Drug Therapy
7
sargramostim
6
Pemetrexed
6
Nivolumab
6
fludarabine
5
aldesleukin
5
Trastuzumab
5
Bevacizumab
5
Taxes
4
Fluorouracil
4
Blood Specimen Collection
4
Amifostine
4
veliparib
3
pegfilgrastim
3
Topotecan
3
Irinotecan
3
IFL protocol
3
Fluorodeoxyglucose F18
3
Etoposide
3
Early Intervention, Educational
3
tariquidar
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Immunohistochemistry
×
Gynecologic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled